Altria Group Inc. (MO)

48.34
NYSE : Consumer Non-Durables
Prev Close 47.97
Day Low/High 47.63 / 48.59
52 Wk Low/High 39.30 / 57.88
Avg Volume 11.64M
Exchange NYSE
Shares Outstanding 1.87B
Market Cap 89.61B
EPS 3.70
P/E Ratio 51.03
Div & Yield 3.36 (6.95%)

Latest News

Even a Recession Can't Burn Out This High-Yield Dividend Stock

Even a Recession Can't Burn Out This High-Yield Dividend Stock

Philip Morris International has paid rising dividends every year since its initial public offering in 2008, which occurred right in the middle of the Great Recession.

5 Dividend Kings for the Coming Storm

5 Dividend Kings for the Coming Storm

These five stocks have shared more than 60 consecutive annual dividend increases with their respective shareholders and their current dividend yields are greater than that for the S&P 500.

The Cannabis Sector and Its Dot-Com Like Meltdown

The Cannabis Sector and Its Dot-Com Like Meltdown

Black-market vaping has made the entire cannabis group toxic.

No Shortage of Candidates for the Next Portfolio of Losers

No Shortage of Candidates for the Next Portfolio of Losers

Dozens of beaten-up stocks could see tax-loss selling into the end of the year; here's a preview of some that could make up the next Tax Loss Selling Portfolio.

Kick the Habit: Altria Group Likely to See Share Value Further Vape-orized

Kick the Habit: Altria Group Likely to See Share Value Further Vape-orized

All kinds of government entities will be lining up against Juul Labs, lawsuits with big awards are coming and who knows what else as MO is in a downtrend with $35 as the next price target.

2 Stocks You Should Consider Shorting This Week

2 Stocks You Should Consider Shorting This Week

These 'bearish bets' are showing both technical and quantitative deterioration.

Clock Is Ticking For Macy's

Clock Is Ticking For Macy's

In the short term, Macy's is not likely to run afoul of dividend problems, but can management transform the company for long-term health? Few retailers have had such success.

Altria Upgraded to Buy at Goldman Sachs

Morningstar High on Pot Growth, Sees U.S. Going Legal by 2023

Morningstar High on Pot Growth, Sees U.S. Going Legal by 2023

Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.

Would You Rather Have an Executive Team Managing the Company or the Stock Price?

Would You Rather Have an Executive Team Managing the Company or the Stock Price?

It all comes down to matching my time frame.

Should Investors Buy the Dip in Canopy Growth Stock?

Should Investors Buy the Dip in Canopy Growth Stock?

Canopy's earnings losses could just be a stepping stone to becoming the industry leader.

Earnings, Earnings and More Earnings, Facebook Results: Market Recon

Earnings, Earnings and More Earnings, Facebook Results: Market Recon

As we have seen so far, in terms of market reaction, there is great reward at the point of sale in beating expectations.

Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space

Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space

CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.

Cannabis Enters Its Most Challenging Stage for Investors and Traders

Not to be outcome by a unicorn company, the unicorn sector of the markets, cannabis, is unleashing a blitzkrieg of news this morning. On the acquisition side, Cresco Labs is buying Origin House (CannaRoyalty) this morning for a small premium. It app...

Altria or Philip Morris International: Which Is the Better Dividend Stock?

Altria or Philip Morris International: Which Is the Better Dividend Stock?

While the two tobacco giants have similar yields, both also have very different businesses, with different growth potential in the years ahead.

Cronos Group Certainly Qualifies for Mainstream Consideration

Cronos Group Certainly Qualifies for Mainstream Consideration

Revenue is where it's at for cannabis in 2019.

2 Big Earnings Reports I'll Be Watching This Week

2 Big Earnings Reports I'll Be Watching This Week

A huge week is coming up for these well-known stocks.

7 Indirect Stock Plays on the Cannabis Sector

7 Indirect Stock Plays on the Cannabis Sector

Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.

Tilray Stock Lights Up as Partnerships Obscure Profitability Problem

Tilray Stock Lights Up as Partnerships Obscure Profitability Problem

The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

In this day and age, companies must be 'disruptors' or get left in the dust.

Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right

Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right

I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.

Nelson Peltz Could Be Key to Cannabis in Consumer Packaged Goods

Nelson Peltz Could Be Key to Cannabis in Consumer Packaged Goods

Aurora's prominent partner could be cannabis' key to breaking into consumer segments.

Watching Shares of Och-Ziff Capital Management

Watching Shares of Och-Ziff Capital Management

With shares breaking above the recent, albeit small, pennant, there might be reason for optimism.

With GreenSky Stock I Tend to Use the Trade What You Know Approach

With GreenSky Stock I Tend to Use the Trade What You Know Approach

GSKY bulls watched as the stock lost two-thirds of its value from its post-IPO high and are now looking for news to turn the bearish tide.

Jim Cramer: My Best Stock Picks for Cannabis and China

Jim Cramer: My Best Stock Picks for Cannabis and China

And why I won't recommend any other stocks in these markets, right now.

Short-Selling Is Really Hard. Just Ask Citron Research

Short-Selling Is Really Hard. Just Ask Citron Research

Examining the influential short-sellers' big winners and losers provides important insights into trading and investing.